Kimora Lee Simmons, a designer, entrepreneur and mother of three debuts Shinto Clinical Skincare in March 2012. Shinto Clinical skincare is artfully designed to meet the changing needs of her skin. As her skin evolved, she was under-whelmed by the promises and claims of other skin care lines and took matters into her own hands.
Armed with her grandmother's strict regimen for luminous skin – a recipe held tightly–lifelong skincare enthusiast Kimora partnered with Makari de Suisse to formulate a clinically proven, high performance skincare line that combats the most problematic skincare concerns. A divine blend of ancient Asian ingredients and breakthrough Western bioactive technology, Shinto Clinical works scientific, sophisticated wonders on the skin of evolving women.
"As a little girl, I watched in wonder as my mother and grandmother stood at the mirror paying meticulous attention to their skin," says Kimora. "As a woman, I'm proud to take those traditions and combine them with clinically proven science to create an ultra luxurious skincare line for all women. I am humbled to be able to bring this hybrid of ancient and modern skincare to women of all complexions and cultures."
The powerful engine behind Shinto Clinical is OMEGAPEARL-18®, an exclusive, clinically proven anti-aging complex formulated from Pearl Powder, Wakame Kelp and Beta-Glucan Mushroom to combat one of the most problematic concerns of pre-mature aging, skin inflammation. Shinto Clinical is packed with anti-oxidant/anti-inflammatory ingredients that have been fused into state-of-the-art delivery systems to rejuvenate and nourish skin.
"Shinto Clinical is a performance driven, result oriented skincare collection created to promote long term anti-aging benefits and restore skin's luminosity and vitality," said Dr Schweiger, a renowned New York dermatologist who backs the collection.
The Shinto Clinical skincare is a collection of results-driven products that will appeal to women in these markets domestic who seek solutions to achieve even skin tone.